Researcher.Life Logo

Bioorganic and Medicinal Chemistry Letters : Impact Factor & More

eISSN: 1464-3405pISSN: 0960-894X

Aims and Scope of Bioorganic and Medicinal Chemistry Letters

Bioorganic & Medicinal Chemistry Letters is a scientific journal focusing on the results of research on the molecular structure of biological organisms and the interaction of biological targets with chemical agents. It is published by Elsevier, which also publishes Bioorganic & Medicinal Chemistry for longer works. Less

Key Metrics

CiteScore
5
Impact Factor
< 5
SJR
Q3Biochemistry
SNIP
0.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Bioorganic and Medicinal Chemistry Letters

Bioorganic and Medicinal Chemistry Letters Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher PERGAMON-ELSEVIER SCIENCE LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1991
Publisher URLVisit website
View less

Planning to publish in Bioorganic and Medicinal Chemistry Letters ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Bioorganic and Medicinal Chemistry Letters

Imperfectly amphipathic design of α-helical antimicrobial peptides demonstrating potent antimicrobial activity with low toxicity.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Synthesis and biological evaluation of novel pyridone derivatives containing 1,3,4-thiadiazol as potential anticancer agents.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Discovery of novel SSRIs for a combination-treatment with pimavanserin.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Novel 2-aminopyrimidine carboxamide derivatives as potential anti-Alzheimer's disease agents: Design, synthesis, biological activity and computational simulation evaluation.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Computational design and biophysical validation of macrocyclic peptides as inhibitors of SLIT2/ROBO1 interaction.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Dipicolinic acid (DPA)-based chelators for zirconium-89 PET imaging applications.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Imperfectly amphipathic design of α-helical antimicrobial peptides demonstrating potent antimicrobial activity with low toxicity.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Synthesis and biological evaluation of novel pyridone derivatives containing 1,3,4-thiadiazol as potential anticancer agents.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Discovery of novel SSRIs for a combination-treatment with pimavanserin.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Novel 2-aminopyrimidine carboxamide derivatives as potential anti-Alzheimer's disease agents: Design, synthesis, biological activity and computational simulation evaluation.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Computational design and biophysical validation of macrocyclic peptides as inhibitors of SLIT2/ROBO1 interaction.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters
Dipicolinic acid (DPA)-based chelators for zirconium-89 PET imaging applications.
  • 1 Aug 2026
  • Bioorganic & medicinal chemistry letters

FAQs on Bioorganic and Medicinal Chemistry Letters